Switch from fingolimod to ozanimod for safety or intolerance reasons

Switch from fingolimod to ozanimod for safety or intolerance reasons

Introduction: Ozanimod is a new-generation sphingosine-1-phosphate (S1P) modulator, approved for the treatment of multiple sclerosis (MS), offering higher selectivity for S1P receptor 1 and 5 (SPR1-5), minimizing potential safety concerns related to S1P3 receptor activation, compared to fingolimod....

Full description

Saved in:
Bibliographic Details
Main Authors: Elisabetta Signoriello, Giuseppe Romano, Matteo Foschi, Aurora Zanghì, Emanuele D’Amico, Roberta Fantozzi, Diego Centonze, Giacomo Lus
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864251328191
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items